TX 1877
Alternative Names: KIH 896Latest Information Update: 07 Apr 2003
At a glance
- Originator University of Tokushima
- Class Radiosensitisers
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 07 Apr 2003 No development reported - Preclinical for Cancer in Japan (unspecified route)
- 20 Jul 2001 This compound is still in active development
- 15 Jan 1999 New profile